S Morandi

549 total citations
22 papers, 310 citations indexed

About

S Morandi is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, S Morandi has authored 22 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Genetics and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in S Morandi's work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). S Morandi is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). S Morandi collaborates with scholars based in Italy and United States. S Morandi's co-authors include Giovanni Barosi, Mario Cazzola, Mario Stefanelli, Giampaolo Merlini, Carlomaurizio Montecucco, R Bettini, Daniele Bertoloni, Luigi Cavanna, Carla Pieresca and Giovanni Grignani and has published in prestigious journals such as Blood, Annals of the Rheumatic Diseases and British Journal of Haematology.

In The Last Decade

S Morandi

22 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Morandi Italy 11 175 144 89 73 63 22 310
JF Tomás Spain 9 283 1.6× 96 0.7× 45 0.5× 63 0.9× 44 0.7× 17 367
Guy Cantin Canada 9 159 0.9× 79 0.5× 56 0.6× 24 0.3× 29 0.5× 23 276
PD Emanuel United States 5 221 1.3× 136 0.9× 24 0.3× 17 0.2× 68 1.1× 9 331
RM Lowenthal Australia 9 254 1.5× 56 0.4× 40 0.4× 91 1.2× 166 2.6× 20 451
Bodey Gp United States 8 104 0.6× 121 0.8× 189 2.1× 49 0.7× 20 0.3× 10 380
Moira Lucesole Italy 8 219 1.3× 85 0.6× 122 1.4× 72 1.0× 34 0.5× 11 373
Gail Miflin United Kingdom 11 275 1.6× 84 0.6× 46 0.5× 52 0.7× 38 0.6× 18 367
Corinna Strupp Germany 5 464 2.7× 268 1.9× 48 0.5× 77 1.1× 75 1.2× 7 485
Margarete A. Fabre United Kingdom 9 236 1.3× 171 1.2× 19 0.2× 49 0.7× 119 1.9× 18 422
WA Kamps Netherlands 7 207 1.2× 40 0.3× 86 1.0× 271 3.7× 37 0.6× 11 394

Countries citing papers authored by S Morandi

Since Specialization
Citations

This map shows the geographic impact of S Morandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Morandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Morandi more than expected).

Fields of papers citing papers by S Morandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Morandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Morandi. The network helps show where S Morandi may publish in the future.

Co-authorship network of co-authors of S Morandi

This figure shows the co-authorship network connecting the top 25 collaborators of S Morandi. A scholar is included among the top collaborators of S Morandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Morandi. S Morandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palumbo, Antonio, Alessandra Bertola, Pellegrino Musto, et al.. (2004). A Prospective Randomized Trial of Oral Melphalan, Prednisone, Thalidomide (MPT) vs Oral Melphalan, Prednisone (MP): An Interim Analysis.. Blood. 104(11). 207–207. 26 indexed citations
2.
3.
4.
Bassan, R, A. Z. S. Rohatiner, Teresa Lerede, et al.. (2000). Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR–ABL rearrangements in B-precursor adult acute lymphoblastic leukemia. The Hematology Journal. 1(4). 226–234. 14 indexed citations
5.
Spedini, Pierangelo, et al.. (2000). Cutaneous flagellate pigmentation by bleomycin.. PubMed. 85(8). 870–870. 2 indexed citations
6.
Bassan, Renato, Enrico Pogliani, Teresa Lerede, et al.. (1999). Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.. PubMed. 84(12). 1088–93. 13 indexed citations
7.
Bassan, Renato, A. Z. S. Rohatiner, Teresa Lerede, et al.. (1999). Role of anthracycline dose intensity in adult Philadelphia chromosome/BCR-ABL positive and negative B-lineage acute lymphoblastic leukemia. 1. 29415. 2 indexed citations
8.
Morandi, S, Annunziata Manna, Elena Sabattini, & Antonio Porcellini. (1996). Rhabdomyosarcoma Presenting as Acute Leukemia. Journal of Pediatric Hematology/Oncology. 18(3). 305–307. 10 indexed citations
9.
Riccardi, Alberto, G. Ucci, Silvia Brugnatelli, et al.. (1994). A PROSPECTIVE, CONTROLLED, NONRANDOMIZED STUDY ON PROPHYLACTIC PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CLODRONATE) IN MULTIPLE-MYELOMA. International Journal of Oncology. 5(4). 833–9. 13 indexed citations
10.
Bettini, R, Carlomaurizio Montecucco, Luigi Cavanna, et al.. (1994). Study of prognosis in Waldenstrom's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility. Blood. 83(10). 2939–2945. 79 indexed citations
11.
Santini, Gino, A. Contu, Antonio Porcellini, et al.. (1992). Mitoxantrone alone or in combination chemotherapy (VeMP) as second-line treatment in relapsed or refractory poor-prognosis non-Hodgkin's lymphoma. A report of the Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG).. PubMed. 76(6). 485–90. 9 indexed citations
12.
Maserati, Emanuela, Pietro Cavalli, Rosario Casalone, S Morandi, & Francesco Pasquali. (1988). Transposition of c-abl oncogene in a case of masked Ph chromosome duplicated in blastic phase. Human Genetics. 78(3). 248–250. 8 indexed citations
13.
Bergonzi, Cesare, Giampaolo Merlini, S Morandi, et al.. (1987). Selective bone marrow involvement of lymphoplasmacytic cells secreting monoclonal IgA rheumatoid factor in a patient with Sjögren's syndrome and serum hyperviscosity.. Annals of the Rheumatic Diseases. 46(12). 938–942. 5 indexed citations
14.
Cazzola, Mario, P Alessandrino, Giovanni Barosi, S Morandi, & Mario Stefanelli. (1979). Quantitative Evaluation of the Mechanisms of the Anaemia in Heterozygous β‐Thalassaemia. Scandinavian Journal of Haematology. 23(2). 107–114. 17 indexed citations
15.
Barosi, Giovanni, S Morandi, Mario Cazzola, Giovanni Ricevuti, & E Ascari. (1978). Abnormal splenic uptake of red cells in long-lasting iron deficiency anemia due to self-induced bleeding (factitious anemia). Annals of Hematology. 37(2). 75–82. 3 indexed citations
16.
Barosi, Giovanni, et al.. (1978). Estimation of Ferrokinetic Parameters by a Mathematical Model in Patients with Primary Acquired Sideroblastic Anaemia. British Journal of Haematology. 39(3). 409–423. 32 indexed citations
17.
Barosi, Giovanni, et al.. (1978). Iron Kinetics and Erythropoiesis in Fanconi's Anaemia. Scandinavian Journal of Haematology. 21(1). 29–39. 6 indexed citations
18.
Barosi, Giovanni, S Morandi, & E Ascari. (1976). On a case of oesophagus involvement by non-Hodgkin's lymphoma. Remission by chemotherapy alone.. PubMed. 61(2). 219–23. 1 indexed citations
19.
Barosi, Giovanni, Carlo Berzuini, M. Cazzola, et al.. (1976). An approach by means of mathematical models to the analysis of ferrokinetic data obtained by liquid scintillation counting of 59Fe.. PubMed. 20(1). 8–22. 9 indexed citations
20.
Barosi, Giovanni, et al.. (1975). Idiopathic pulmonary hemosiderosis: ferrokinetic remarks.. PubMed. 60(3). 322–31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JF Tomás Breakdown of academic impact, for papers by Guy Cantin Breakdown of academic impact, for papers by PD Emanuel Breakdown of academic impact, for papers by RM Lowenthal Breakdown of academic impact, for papers by Bodey Gp Breakdown of academic impact, for papers by Moira Lucesole Breakdown of academic impact, for papers by Gail Miflin Breakdown of academic impact, for papers by Corinna Strupp Breakdown of academic impact, for papers by Margarete A. Fabre Breakdown of academic impact, for papers by WA Kamps
Rankless by CCL
2026